Microbial degradation of fluorinated drugs: biochemical pathways, impacts on the environment and potential applications
- 1 February 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Applied Microbiology and Biotechnology
- Vol. 100 (6), 2617-2627
- https://doi.org/10.1007/s00253-016-7304-3
Abstract
Since the discovery over 60 years ago of fluorocortisone’s biological properties (9-α-Fluoro derivatives of cortisone and hydrocortisone; Fried J and Sabo EF, J Am Chem Soc 76: 1455–1456, 1954), the number of fluorinated drugs has steadily increased. With the improvement in synthetic methodologies, this trend is likely to continue and will lead to the introduction of new fluorinated substituents into pharmaceutical compounds. Although the biotransformation of organofluorine compounds by microorganisms has been well studied, specific investigations on fluorinated drugs are relatively few, despite the increase in the number and variety of fluorinated drugs that are available. The strength of the carbon-fluorine bond conveys stability to fluorinated drugs; thus, they are likely to be recalcitrant in the environment or may be partially metabolized to a more toxic metabolite. This review examines the research done on microbial biotransformation and biodegradation of fluorinated drugs and highlights the importance of understanding how microorganisms interact with this class of compound from environmental, clinical and biotechnological perspectives.Keywords
This publication has 67 references indexed in Scilit:
- Biocatalytic synthesis of flavones and hydroxyl-small molecules by recombinant Escherichia coli cells expressing the cyanobacterial CYP110E1 geneMicrobial Cell Factories, 2012
- Metabolite proving fungal cleavage of the aromatic core part of a fluoroquinolone antibioticAMB Express, 2012
- Modification of Norfloxacin by a Microbacterium sp. Strain Isolated from a Wastewater Treatment PlantApplied and Environmental Microbiology, 2011
- Production of human metabolites of the anti-cancer drug flutamide via biotransformation in Cunninghamella speciesBiotechnology Letters, 2010
- Biotransformation of Flurbiprofen by Cunninghamella SpeciesApplied and Environmental Microbiology, 2010
- Biodegradation of polyfluorinated biphenyl in bacteriaBiodegradation, 2010
- Chemo-enzymatic fluorination of unactivated organic compoundsNature Chemical Biology, 2008
- Purification and properties of fluoroacetate dehalogenase from Pseudomonas fluorescens DSM 8341Biotechnology Letters, 2008
- Transformation of the Antibacterial Agent Norfloxacin by Environmental MycobacteriaApplied and Environmental Microbiology, 2006
- Arylsulfur PentafluoridesJournal of the American Chemical Society, 1962